Keyword Search Year None202420232022202120202019201820172016201520142013 Nov 19, 2024 Labcorp CFO Glenn Eisenberg Announces Plans to Retire Read more » Oct 24, 2024 Labcorp Announces 2024 Third Quarter Results Read more » Oct 10, 2024 Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test Read more » Oct 10, 2024 Labcorp Declares Quarterly Dividend Read more » Sep 24, 2024 Labcorp to Announce Third Quarter Financial Results on October 24, 2024 Read more » Sep 17, 2024 Cinven to sell minority stake in SYNLAB to strategic investor Labcorp Read more » Sep 16, 2024 Labcorp Prices $650,000,000 in 4.350% Senior Notes Due 2030, $500,000,000 in 4.550% Senior Notes Due 2032 and $850,000,000 in 4.800% Senior Notes Due 2034 Read more » Sep 16, 2024 Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health Read more » Sep 09, 2024 Labcorp to Acquire Select Outreach Services from Ballad Health Read more » Sep 03, 2024 Labcorp to Speak at the Baird 2024 Global Healthcare Conference Read more » Aug 05, 2024 Labcorp Finalizes Acquisition of Select Assets of Invitae Read more » Aug 02, 2024 Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx Read more » Aug 01, 2024 Labcorp Announces 2024 Second Quarter Results Read more » Jul 30, 2024 Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities Read more » Jul 25, 2024 Labcorp Declares Quarterly Dividend Read more » Jul 11, 2024 Labcorp and Naples Comprehensive Healthcare Announce Strategic Agreement for Lab Operations Read more » Jul 01, 2024 Labcorp to Announce Second Quarter Financial Results on August 1, 2024 Read more » Jun 17, 2024 Labcorp Launches Global Trial Connect to Accelerate Clinical Trials Read more » Jun 03, 2024 Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio Read more » May 30, 2024 Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting Read more » May 28, 2024 Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference Read more » May 16, 2024 Labcorp Announces Retirement of Dr. R. Sanders Williams and Mr. Jean-Luc Bélingard from Its Board of Directors Read more » May 15, 2024 Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy Read more » May 08, 2024 Labcorp to Webcast Its Annual Meeting of Shareholders Read more » May 07, 2024 Invitae Receives Court Approval for Sale to Labcorp Read more » Current page 1 Page 2 Next page next › Last page last »
